April 26, 2022 C-Path in Europe: Moving Global Regulatory Science Forward Critical Path Institute is a catalyst for innovation that accelerates the path to a healthier world...
April 11, 2022 Quantitative System Pharmacology as a Legitimate Approach to Examine Extrapolation Strategies used to Support Pediatric Drug Development; Azer K, Barrett JS
April 11, 2022 Role of Disease Progression Models in Drug Development. Pharmaceutical Research; Jeffrey S Barrett, Tim Nicholas, Karim Azer, Brian W Corrigan
March 28, 2022 Digital Health Technologies for Remote Data Acquisition in Clinical Investigations C-Path thanks and commends FDA for inviting public comments as part of the creation of a guidance document for Digital Health...
March 21, 2022 Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials
March 18, 2022 Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease Sensor data from digital health technologies (DHTs) used in clinical trials provides a valuable source of information...
March 11, 2022 Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies The development of therapies to prevent or delay the onset of type 1 diabetes (T1D) remains challenging, and there is a lack of qu
March 7, 2022 eTRANSAFE: Building a sustainable framework to share reproducible drug safety knowledge with the public domain
March 2, 2022 Measurement Comparability of Electronic and Paper Administration of Visual Analogue Scales: A Review of Published Studies
February 23, 2022 Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based....
